Riccardo Vecchio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Riccardo Vecchio has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Anna Odone
Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy
12 shared publications - Paola Bertuccio
Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy
5 shared publications - Andrea Amerio
Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Section of Psychiatry, University of Genoa, Genoa, Italy
3 shared publications - Johnnatas Mikael Lopes
Universidade Federal do Vale do São Francisco, Brazil
3 shared publications - Lorenzo Blandi
School of Public Health, Vita-Salute San Raffaele University, 20132 Milan, Italy
3 shared publications - Alessandra Costanza
Department of Psychiatry, Faculty of Medicine, Geneva University (UNIGE), 24 Rue du General-Dufour, 1211 Geneva, Switzerland
2 shared publications
Latest Publications
- Open Access
- 11 June 2026
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 71 (5) , 108474
Alcohol consumption patterns before and after retirement: a longitudinal cohort study within the Survey of Health, Ageing and Retirement in Europe
- 11 June 2026
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 71 (5) , 108474
Open AccessAlcohol consumption patterns before and after retirement: a longitudinal cohort study within the Survey of Health, Ageing and Retirement in Europe
- Open Access
- 24 February 2026
- Published by MDPI AG in Neurology International
- Vol. 18 (3) , 42
Subjective Cognitive Decline in Brazilian Adults: Prevalence and Associated Social, Lifestyle, and Health-Related Factors: A Nationally Representative Cross-Sectional Analysis from the ELSI-Brazil Cohort
Background/Objectives: Subjective cognitive decline (SCD) is an early stage of dementia, although its risk factors remain unclear. We estimated the prevalence of SCD and its associated dementia risk factors in Brazilian adults. Methods: This cross-sectional study is based on data from the second wave (2019–2021) of the Brazilian longitudinal study of aging (ELSI-Brazil) and a nationally representative sample of adults aged ≥50 years. Prevalence of SCD was estimated and defined as self-reported cognitive decline without objective impairment or dementia diagnosis, and the adjusted odds ratios (OR) with 95% confidence intervals (CI) were estimated through logistic regression models. Results: Of 6631 participants, 57.5% were women, and 54.4% were non-white, with a mean age of 65.1 years (standard deviation: ±9.70). SCD prevalence was 19.7% (95% CI 18.6–20.9) for a total of 1346 individuals. Significantly strong positive associations with SCD were observed for sociodemographic factors, particularly lower education (OR = 2.79, 95% CI: 2.02–3.85), as well as older age, non-white ethnicity, and lower income (ORs ranging from 1.50 to 1.79). Lifestyle factors, including loneliness and sedentary behavior, showed moderate associations (OR = 1.33 and 1.35, respectively). Among health-related conditions, multimorbidity was significantly associated with higher odds of SCD (OR = 1.40 for ≥3 chronic diseases), with the strongest association observed for hearing loss (OR = 2.29, 95% CI: 1.93–2.71). Diabetes, visual loss, and depressive symptoms showed more modest significant associations (OR 1.25 to 1.31). Conclusions: Our findings support the prioritization of vulnerable populations in public health strategies aimed at promoting healthy ageing and reducing social and health inequalities. Longitudinal studies are needed to clarify whether modifying associated factors may influence SCD trajectories.
- 24 February 2026
- Published by MDPI AG in Neurology International
- Vol. 18 (3) , 42
Open AccessSubjective Cognitive Decline in Brazilian Adults: Prevalence and Associated Social, Lifestyle, and Health-Related Factors: A Nationally Representative Cross-Sectional Analysis from the ELSI-Brazil Cohort
Background/Objectives: Subjective cognitive decline (SCD) is an early stage of dementia, although its risk factors remain unclear. We estimated the prevalence of SCD and its associated dementia risk factors in Brazilian adults. Methods: This cross-sectional study is based on data from the second wave (2019–2021) of the Brazilian longitudinal study of aging (ELSI-Brazil) and a nationally representative sample of adults aged ≥50 years. Prevalence of SCD was estimated and defined as self-reported cognitive decline without objective impairment or dementia diagnosis, and the adjusted odds ratios (OR) with 95% confidence intervals (CI) were estimated through logistic regression models. Results: Of 6631 participants, 57.5% were women, and 54.4% were non-white, with a mean age of 65.1 years (standard deviation: ±9.70). SCD prevalence was 19.7% (95% CI 18.6–20.9) for a total of 1346 individuals. Significantly strong positive associations with SCD were observed for sociodemographic factors, particularly lower education (OR = 2.79, 95% CI: 2.02–3.85), as well as older age, non-white ethnicity, and lower income (ORs ranging from 1.50 to 1.79). Lifestyle factors, including loneliness and sedentary behavior, showed moderate associations (OR = 1.33 and 1.35, respectively). Among health-related conditions, multimorbidity was significantly associated with higher odds of SCD (OR = 1.40 for ≥3 chronic diseases), with the strongest association observed for hearing loss (OR = 2.29, 95% CI: 1.93–2.71). Diabetes, visual loss, and depressive symptoms showed more modest significant associations (OR 1.25 to 1.31). Conclusions: Our findings support the prioritization of vulnerable populations in public health strategies aimed at promoting healthy ageing and reducing social and health inequalities. Longitudinal studies are needed to clarify whether modifying associated factors may influence SCD trajectories.
- Open Access
- 24 February 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (3) , 131
Correction: Penati et al. High Outcome-Reporting Bias in Randomized-Controlled Trials of Acupuncture for Cancer Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Epidemiological Study. Curr. Oncol. 2025, 32, 462
The authors inadvertently omitted to indicate a second affiliation of Anna Odone in the original publication
- 24 February 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (3) , 131
Open AccessCorrection: Penati et al. High Outcome-Reporting Bias in Randomized-Controlled Trials of Acupuncture for Cancer Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Epidemiological Study. Curr. Oncol. 2025, 32, 462
The authors inadvertently omitted to indicate a second affiliation of Anna Odone in the original publication
- Open Access
- 3 February 2026
- Published by MDPI AG in Preprints.org
Subjective Cognitive Decline in Brazilian Adults: Prevalence and Associated Social, Lifestyle, and Health-related Factors: a Nationally Representative Cross-Sectional Analysis from the ELSI-Brazil Cohort
Background/Objectives: Subjective cognitive decline (SCD) is an early stage of dementia, although its risk factors remain unclear. We estimated prevalence of SCD and its associated dementia risk factors in Brazilian adults. Methods: Cross-sectional study based on data from the second wave (2019-2021) of The Brazilian Longitudinal Study of Aging (ELSI-Brazil), on a nationally representative sample of adults aged ≥50 years. Prevalence of SCD was estimated, defined as self-reported cognitive decline without objective impairment or dementia diagnosis, and adjusted odds ratios (OR) with 95% confidence intervals (CI) were estimated through logistic regression models. Results: Of 6,631 participants, 57.5% were women, 54.4% individuals of non-white race, with a mean age of 65.1 years (standard deviation: ±9.70). SCD prevalence was 19.7% (95%CI 18.6-20.9) for a total of 1,346 individuals. Significant higher odds of SCD emerged with increasing age (OR=1.57; 95%CI: 1.19-2.09 for the oldest ages; p-value for trend <0.01), non-white race (OR=1.53; 95%CI:1.30-1.79), lower education (OR=2.79; 95%CI: 2.02-3.85 for the lowest compared to the highest level, p for trend <0.01), lower income (OR=1.58; 95%CI:1.14-2.21 for the lowest compared to the highest level; p for trend <0.01), loneliness (OR=1.35; 95%CI:1.15-1.59), and sedentary lifestyle (OR=1.33; 95%CI: 1.13-1.59). SCD was also associated with multimorbidity (OR=1.40; 95%CI:1.06-1.84 for 3+ compared to none chronic diseases), diabetes (OR=1.25; 95% CI: 1.02-1.53), visual loss (OR=1.31; 95% CI:1.11-1.56), hearing loss (OR=2.29; 95% CI:1.93-2.71), and depressive symptoms (OR=1.30; 95%CI:1.05-1.60). Conclusions: Our findings highlight the need for strategies to address early cognitive decline and reduce health inequalities in vulnerable populations.
- 3 February 2026
- Published by MDPI AG in Preprints.org
Open AccessSubjective Cognitive Decline in Brazilian Adults: Prevalence and Associated Social, Lifestyle, and Health-related Factors: a Nationally Representative Cross-Sectional Analysis from the ELSI-Brazil Cohort
Background/Objectives: Subjective cognitive decline (SCD) is an early stage of dementia, although its risk factors remain unclear. We estimated prevalence of SCD and its associated dementia risk factors in Brazilian adults. Methods: Cross-sectional study based on data from the second wave (2019-2021) of The Brazilian Longitudinal Study of Aging (ELSI-Brazil), on a nationally representative sample of adults aged ≥50 years. Prevalence of SCD was estimated, defined as self-reported cognitive decline without objective impairment or dementia diagnosis, and adjusted odds ratios (OR) with 95% confidence intervals (CI) were estimated through logistic regression models. Results: Of 6,631 participants, 57.5% were women, 54.4% individuals of non-white race, with a mean age of 65.1 years (standard deviation: ±9.70). SCD prevalence was 19.7% (95%CI 18.6-20.9) for a total of 1,346 individuals. Significant higher odds of SCD emerged with increasing age (OR=1.57; 95%CI: 1.19-2.09 for the oldest ages; p-value for trend <0.01), non-white race (OR=1.53; 95%CI:1.30-1.79), lower education (OR=2.79; 95%CI: 2.02-3.85 for the lowest compared to the highest level, p for trend <0.01), lower income (OR=1.58; 95%CI:1.14-2.21 for the lowest compared to the highest level; p for trend <0.01), loneliness (OR=1.35; 95%CI:1.15-1.59), and sedentary lifestyle (OR=1.33; 95%CI: 1.13-1.59). SCD was also associated with multimorbidity (OR=1.40; 95%CI:1.06-1.84 for 3+ compared to none chronic diseases), diabetes (OR=1.25; 95% CI: 1.02-1.53), visual loss (OR=1.31; 95% CI:1.11-1.56), hearing loss (OR=2.29; 95% CI:1.93-2.71), and depressive symptoms (OR=1.30; 95%CI:1.05-1.60). Conclusions: Our findings highlight the need for strategies to address early cognitive decline and reduce health inequalities in vulnerable populations.
- Open Access
- 20 January 2026
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 69 (1) , e12
Age- and sex-patterns of suicide trends in Europe: 1990–2022 comparative analysis of official WHO mortality data – CORRIGENDUM
- 20 January 2026
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 69 (1) , e12
Open AccessAge- and sex-patterns of suicide trends in Europe: 1990–2022 comparative analysis of official WHO mortality data – CORRIGENDUM
- Open Access
- 2 December 2025
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 68 (1) , 1-21
Age- and sex-patterns of suicide trends in Europe: 1990–2022 comparative analysis of official WHO mortality data
Background: Understanding how suicide rates vary across age, sex, and geography is essential to designing effective prevention strategies. We examined long-term trends in suicide mortality across European countries over three decades, with a focus on age-specific trajectories. Methods: Using the WHO mortality database, we computed annual sex- and age-specific suicide rates (10–14 to 85+ age groups) from 1990 to 2022, for the most populous European countries, and aggregated rates for the EU-27 and four geographical areas (North, West, South, and Centre-East Europe). We also calculated percentage differences across four time periods (1990–1994, 2000–2004, 2010–2014, and 2020–2022), according to data availability. Results: Suicide rates increased with age, peaking in older individuals (85+) in most countries (e.g., 82.0/100,000 in France in 2020–2022, 77.1/100,000 in Germany among males, in 2020), except in the UK and Northern Europe, where rates peaked at middle age (∼22/100,000 at 45–49, in 2020). EU-27 suicide rates in 2020 ranged from 5.5/100,000 (age 15–19) to 58.2/100,000 (85+) among males, and from 2.6 (15–19) to 8.6/100,000 (85+) among females. Male suicide rates were 3 to 8 times higher than female rates across all ages. While overall rates declined since 1990 in most countries, youth suicide increased after 2010 in Western (e.g., +12%, girls 15–19), Southern (+24.5%, girls 15–19), and Northern (+44%, girls 15–19 and 20–24) Europe. Rates among young and middle-aged adults recently rose in Spain, the UK, and Northern Europe, while they declined in Eastern Europe after the 1990s. Conclusions: Despite overall declines, our findings highlight marked heterogeneity in sex- and age-specific trends in suicide mortality across Europe. These patterns call for age-tailored prevention strategies that address evolving psychosocial stressors and structural determinants across the lifespan.
- 2 December 2025
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 68 (1) , 1-21
Open AccessAge- and sex-patterns of suicide trends in Europe: 1990–2022 comparative analysis of official WHO mortality data
Background: Understanding how suicide rates vary across age, sex, and geography is essential to designing effective prevention strategies. We examined long-term trends in suicide mortality across European countries over three decades, with a focus on age-specific trajectories. Methods: Using the WHO mortality database, we computed annual sex- and age-specific suicide rates (10–14 to 85+ age groups) from 1990 to 2022, for the most populous European countries, and aggregated rates for the EU-27 and four geographical areas (North, West, South, and Centre-East Europe). We also calculated percentage differences across four time periods (1990–1994, 2000–2004, 2010–2014, and 2020–2022), according to data availability. Results: Suicide rates increased with age, peaking in older individuals (85+) in most countries (e.g., 82.0/100,000 in France in 2020–2022, 77.1/100,000 in Germany among males, in 2020), except in the UK and Northern Europe, where rates peaked at middle age (∼22/100,000 at 45–49, in 2020). EU-27 suicide rates in 2020 ranged from 5.5/100,000 (age 15–19) to 58.2/100,000 (85+) among males, and from 2.6 (15–19) to 8.6/100,000 (85+) among females. Male suicide rates were 3 to 8 times higher than female rates across all ages. While overall rates declined since 1990 in most countries, youth suicide increased after 2010 in Western (e.g., +12%, girls 15–19), Southern (+24.5%, girls 15–19), and Northern (+44%, girls 15–19 and 20–24) Europe. Rates among young and middle-aged adults recently rose in Spain, the UK, and Northern Europe, while they declined in Eastern Europe after the 1990s. Conclusions: Despite overall declines, our findings highlight marked heterogeneity in sex- and age-specific trends in suicide mortality across Europe. These patterns call for age-tailored prevention strategies that address evolving psychosocial stressors and structural determinants across the lifespan.
- Open Access
- 23 October 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (11) , 591
Barriers and Facilitators to Cervical Cancer Screening in Northern Uganda: Qualitative Insights from Healthcare Workers and Administrators
Background: Cervical cancer (CC) is the most common cancer among Ugandan women and the leading cause of cancer mortality. Screening has proven to be a cost-effective method in reducing its burden, yet uptake among women of reproductive age remains alarmingly low, with national adherence rates under 10%. Objective: This study explored healthcare workers’ (HWs) perspectives on barriers and facilitators to screening and attitudes toward implementing human papillomavirus (HPV) DNA testing with self-collection. Methods: A qualitative research design was employed. Twenty semi-structured interviews were conducted with purposively sampled healthcare providers and administrators across different cadres at a referral hospital and three peripheral health centres in Northern Uganda. Interviews were analysed thematically using the Social Ecological Model. Data collection and analysis proceeded iteratively until thematic saturation. Reporting follows the Consolidated Criteria for Reporting Qualitative Research (COREQ). Results: Participants described individual and interpersonal barriers such as limited awareness, poor preventive health-seeking, fear of results, stigma, and limited male involvement. Organisational barriers included staff shortages, weak referral practices, and stock-outs of supplies, while policy constraints included limited governmental support and competing priorities. Facilitators included targeted health education, routine referrals from all service entry points, outreach screening, and donor support. Most respondents favoured scaling up of self-collected HPV testing, citing higher acceptability and feasibility for outreach, contingent on sustained supplies, laboratory capacity, and training. Conclusions: Multi-level interventions are needed to strengthen facility workflows, staff capability, community engagement, and reliable supply chains. Expanding access to self-collected HPV testing may overcome major barriers and represents a promising strategy to increase screening uptake in Uganda and similar low resource settings.
- 23 October 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (11) , 591
Open AccessBarriers and Facilitators to Cervical Cancer Screening in Northern Uganda: Qualitative Insights from Healthcare Workers and Administrators
Background: Cervical cancer (CC) is the most common cancer among Ugandan women and the leading cause of cancer mortality. Screening has proven to be a cost-effective method in reducing its burden, yet uptake among women of reproductive age remains alarmingly low, with national adherence rates under 10%. Objective: This study explored healthcare workers’ (HWs) perspectives on barriers and facilitators to screening and attitudes toward implementing human papillomavirus (HPV) DNA testing with self-collection. Methods: A qualitative research design was employed. Twenty semi-structured interviews were conducted with purposively sampled healthcare providers and administrators across different cadres at a referral hospital and three peripheral health centres in Northern Uganda. Interviews were analysed thematically using the Social Ecological Model. Data collection and analysis proceeded iteratively until thematic saturation. Reporting follows the Consolidated Criteria for Reporting Qualitative Research (COREQ). Results: Participants described individual and interpersonal barriers such as limited awareness, poor preventive health-seeking, fear of results, stigma, and limited male involvement. Organisational barriers included staff shortages, weak referral practices, and stock-outs of supplies, while policy constraints included limited governmental support and competing priorities. Facilitators included targeted health education, routine referrals from all service entry points, outreach screening, and donor support. Most respondents favoured scaling up of self-collected HPV testing, citing higher acceptability and feasibility for outreach, contingent on sustained supplies, laboratory capacity, and training. Conclusions: Multi-level interventions are needed to strengthen facility workflows, staff capability, community engagement, and reliable supply chains. Expanding access to self-collected HPV testing may overcome major barriers and represents a promising strategy to increase screening uptake in Uganda and similar low resource settings.
- Open Access
- 14 October 2025
- Published by MDPI AG in Neurology International
- Vol. 17 (10) , 172
Latent Profiles Based on Combined Risk Factors for Cognitive Decline in European Older Adults: A Retrospective Study Based on the SHARE HCAP Project
Background/Objectives: Cognitive decline is common in ageing, ranging from mild to severe manifestations. Although several modifiable risk factors have been identified, they are typically examined individually. This study aimed to identify latent profiles based on combinations of dementia risk factors and to quantify the associations with cognitive impairment in a European population of older adults. Methods: Based on the SHARE HCAP project, we conducted a retrospective longitudinal study by linking individual data from wave 6 (2015) and wave 9 (2021–2022). The sample included 2685 individuals aged 50+. The study outcome was cognitive status, assessed using standardised neurological tests and questionnaire and categorised as normal cognition, mild cognitive impairment (MCI), or severe cognitive impairment (SCI). The exposures included clinical, psychosocial, and lifestyle variables. Latent Class Analysis (LCA) was applied to identify distinct profiles, and multinomial logistic regression models were carried out to estimate associations between latent profiles and cognitive status, expressed as odds ratios (ORs) with 95% confidence intervals (CI). Results: The study sample included 2326 participants, of whom 25.1% with MCI and 9.4% with SCI. Through LCA, we identified four profiles: Low-risk, Combined Cluster, Inactive Behaviour, and Cardiometabolic Risk. Compared with the Low-risk profile, the odds of MCI were significantly higher for Combined Cluster profile (OR = 3.11; 95% CI: 2.38–4.06) and CR (OR = 1.44; 95% CI: 1.07–1.93). For SCI, elevated odds were observed for Combined Cluster (OR = 7.30; 95% CI: 4.47–11.92), Cardiometabolic Risk (OR = 2.31; 95% CI: 1.31–4.05), and Inactive Behaviour (OR = 1.87; 95% CI: 1.01–3.48). Conclusions: Four latent profiles were identified, each showing distinct associations with MCI and SCI. The Combined Cluster—characterised by poor mental health, limited physical activity, and hypertension—showed the highest odds of cognitive impairment. Public health strategies should prioritise integrated actions against these risk factors.
- 14 October 2025
- Published by MDPI AG in Neurology International
- Vol. 17 (10) , 172
Open AccessLatent Profiles Based on Combined Risk Factors for Cognitive Decline in European Older Adults: A Retrospective Study Based on the SHARE HCAP Project
Background/Objectives: Cognitive decline is common in ageing, ranging from mild to severe manifestations. Although several modifiable risk factors have been identified, they are typically examined individually. This study aimed to identify latent profiles based on combinations of dementia risk factors and to quantify the associations with cognitive impairment in a European population of older adults. Methods: Based on the SHARE HCAP project, we conducted a retrospective longitudinal study by linking individual data from wave 6 (2015) and wave 9 (2021–2022). The sample included 2685 individuals aged 50+. The study outcome was cognitive status, assessed using standardised neurological tests and questionnaire and categorised as normal cognition, mild cognitive impairment (MCI), or severe cognitive impairment (SCI). The exposures included clinical, psychosocial, and lifestyle variables. Latent Class Analysis (LCA) was applied to identify distinct profiles, and multinomial logistic regression models were carried out to estimate associations between latent profiles and cognitive status, expressed as odds ratios (ORs) with 95% confidence intervals (CI). Results: The study sample included 2326 participants, of whom 25.1% with MCI and 9.4% with SCI. Through LCA, we identified four profiles: Low-risk, Combined Cluster, Inactive Behaviour, and Cardiometabolic Risk. Compared with the Low-risk profile, the odds of MCI were significantly higher for Combined Cluster profile (OR = 3.11; 95% CI: 2.38–4.06) and CR (OR = 1.44; 95% CI: 1.07–1.93). For SCI, elevated odds were observed for Combined Cluster (OR = 7.30; 95% CI: 4.47–11.92), Cardiometabolic Risk (OR = 2.31; 95% CI: 1.31–4.05), and Inactive Behaviour (OR = 1.87; 95% CI: 1.01–3.48). Conclusions: Four latent profiles were identified, each showing distinct associations with MCI and SCI. The Combined Cluster—characterised by poor mental health, limited physical activity, and hypertension—showed the highest odds of cognitive impairment. Public health strategies should prioritise integrated actions against these risk factors.
- Open Access
- 3 September 2025
- Published by MDPI AG in Preprints.org
Barriers and Facilitators to Cervical Cancer Screening in Northern Uganda: Qualitative Insights from Healthcare Workers
Background: Cervical cancer (CC) is the most common among Ugandan women and the leading cause of cancer mortality. Screening has proven to be a cost-effective method in reducing its burden, yet uptake among women of reproductive age remains alarmingly low, with national adherence rates under 10%. Objective: To explore healthcare workers (HWs) perspectives on barriers and facilitators to screening and attitudes toward implementing HPV DNA testing with self-collection. Methods: A qualitative research design was employed. Twenty semi-structured interviews were conducted with purposively sampled healthcare providers and administrators across different cadres at a referral hospital and three peripheral health centres in Northern Uganda. Interviews were analysed thematically using the Social Ecological Model. Data collection and analysis proceeded iteratively until thematic saturation. Reporting follows COREQ. Results: Participants described individual and interpersonal barriers such as limited awareness, poor preventive health-seeking, fear of results, stigma, and limited male involvement. Organisational barriers included staff shortages, weak referral practices, and stock-outs of supplies, while policy constraints included limited governmental support and competing priorities. Facilitators included targeted health education, routine referrals from all service entry points, outreach screening, and donor support. Most respondents favoured scaling up of self-collected HPV testing, citing higher acceptability and feasibility for outreach, contingent on sustained supplies, laboratory capacity, and training. Conclusions: Multi-level interventions are needed to strengthen facility workflows, staff capability, community engagement, and reliable supply chains. Expanding access to self-collected HPV testing may overcome major barriers and represents a promising strategy to increase screening uptake in Uganda and similar low resource settings.
- 3 September 2025
- Published by MDPI AG in Preprints.org
Open AccessBarriers and Facilitators to Cervical Cancer Screening in Northern Uganda: Qualitative Insights from Healthcare Workers
Background: Cervical cancer (CC) is the most common among Ugandan women and the leading cause of cancer mortality. Screening has proven to be a cost-effective method in reducing its burden, yet uptake among women of reproductive age remains alarmingly low, with national adherence rates under 10%. Objective: To explore healthcare workers (HWs) perspectives on barriers and facilitators to screening and attitudes toward implementing HPV DNA testing with self-collection. Methods: A qualitative research design was employed. Twenty semi-structured interviews were conducted with purposively sampled healthcare providers and administrators across different cadres at a referral hospital and three peripheral health centres in Northern Uganda. Interviews were analysed thematically using the Social Ecological Model. Data collection and analysis proceeded iteratively until thematic saturation. Reporting follows COREQ. Results: Participants described individual and interpersonal barriers such as limited awareness, poor preventive health-seeking, fear of results, stigma, and limited male involvement. Organisational barriers included staff shortages, weak referral practices, and stock-outs of supplies, while policy constraints included limited governmental support and competing priorities. Facilitators included targeted health education, routine referrals from all service entry points, outreach screening, and donor support. Most respondents favoured scaling up of self-collected HPV testing, citing higher acceptability and feasibility for outreach, contingent on sustained supplies, laboratory capacity, and training. Conclusions: Multi-level interventions are needed to strengthen facility workflows, staff capability, community engagement, and reliable supply chains. Expanding access to self-collected HPV testing may overcome major barriers and represents a promising strategy to increase screening uptake in Uganda and similar low resource settings.
- Open Access
- 15 August 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (8) , 462
High Outcome-Reporting Bias in Randomized-Controlled Trials of Acupuncture for Cancer Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Epidemiological Study
Selective outcome-reporting bias refers to the selective reporting of a subset of study findings. This methodological limitation may occur in cancer-related acupuncture studies, where valid empirical studies on psychometric performance are still lacking. We assessed the risk of selective outcome reporting bias in studies published in English that were included in a systematic review on acupuncture for preventing cancer chemotherapy-induced nausea and vomiting. For each study, we searched for registry availability and, if present, assessed its validity. We described each study outcome (nausea, vomiting, or both) according to the following seven items: type of outcome, domain, specific measurement, specific metric, type of data, methods of aggregation, and timepoint unit and time. Eleven studies published between 1987 and 2019 in English were evaluated. Only four (36%) had a registry, of which only two were prospective and therefore considered valid. Discrepancies were found in the specific measurement of the outcome in two studies and in the specific metric. In many other cases, discrepancies were not evaluable due to missing information. No study reported complete outcomes as planned in the published protocol. Communication about the importance of prospective trial registration, including outcome details, should be enforced to reduce the risk of selective outcome reporting bias in oncology acupuncture studies.
- 15 August 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (8) , 462
Open AccessHigh Outcome-Reporting Bias in Randomized-Controlled Trials of Acupuncture for Cancer Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Epidemiological Study
Selective outcome-reporting bias refers to the selective reporting of a subset of study findings. This methodological limitation may occur in cancer-related acupuncture studies, where valid empirical studies on psychometric performance are still lacking. We assessed the risk of selective outcome reporting bias in studies published in English that were included in a systematic review on acupuncture for preventing cancer chemotherapy-induced nausea and vomiting. For each study, we searched for registry availability and, if present, assessed its validity. We described each study outcome (nausea, vomiting, or both) according to the following seven items: type of outcome, domain, specific measurement, specific metric, type of data, methods of aggregation, and timepoint unit and time. Eleven studies published between 1987 and 2019 in English were evaluated. Only four (36%) had a registry, of which only two were prospective and therefore considered valid. Discrepancies were found in the specific measurement of the outcome in two studies and in the specific metric. In many other cases, discrepancies were not evaluable due to missing information. No study reported complete outcomes as planned in the published protocol. Communication about the importance of prospective trial registration, including outcome details, should be enforced to reduce the risk of selective outcome reporting bias in oncology acupuncture studies.